Past research has focussed on achieving a more precise characterization of the dementia syndrome in HD and relating it to other clinical and neuroradiological features. In the next funding period, three studies are planned: 1) A 5-year, longitudinal study of dementia in HD will be performed. Forty new patients per year will be entered and will have annual neuropsychological examinations and biannual brain MRI scans. Alterations in particular cognitive domains over time will be assessed as a function of age of onset of disease and asymmetries in clinical presentation. Patterns of impairment and rate of change will be related to measures of frontal cortical and striatal degeneration on MRI scans. 2) Memory deficits will be subject to further study, concentrating on aspects of explicit memory (recall and recognition) and implicit memory (skill acquisition, priming, and activation). It is proposed that performance on experimental task of explicit memory will be correlated to MRI measures of frontal cortical atrophy, while implicit memory task performance will be related to striatal degeneration. 3) The factors that render HD patients disabled will be assessed. The relative contributions of poor motor control, specific cognitive deficits, and emotional symptoms and disorders will be evaluated. Sources of occupational disability will be sought in patients' longitudinal neuropsychological performance and by interviews with employers. Impaired ability to drive an automobile will be assessed in a driving simulator and the results correlated with neuropsychological test performance. These studies will further our understanding of the relationship between fronto-striatal pathology and specific cognitive impairments in HD, while at the same time provide practical knowledge that will be valuable in the care and management of afflicted patients.

Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Faria, Andreia V; Ratnanather, J Tilak; Tward, Daniel J et al. (2016) Linking white matter and deep gray matter alterations in premanifest Huntington disease. Neuroimage Clin 11:450-460
Krause, Amanda; Mitchell, Claire; Essop, Fahmida et al. (2015) Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatr Genet 168:573-85
Ross, Christopher A; Pantelyat, Alex; Kogan, Jane et al. (2014) Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction. Mov Disord 29:1351-8
Hua, Jun; Unschuld, Paul G; Margolis, Russell L et al. (2014) Elevated arteriolar cerebral blood volume in prodromal Huntington's disease. Mov Disord 29:396-401
Unschuld, Paul G; Liu, Xinyang; Shanahan, Megan et al. (2013) Prefrontal executive function associated coupling relates to Huntington's disease stage. Cortex 49:2661-73
Unschuld, Paul G; Edden, Richard A E; Carass, Aaron et al. (2012) Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov Disord 27:895-902
Guo, Zhihong; Rudow, Gay; Pletnikova, Olga et al. (2012) Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Mov Disord 27:1379-86
Fu, Jinrong; Jin, Jing; Cichewicz, Robert H et al. (2012) trans-(-)-?-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem 287:24460-72
Rosenblatt, Adam; Kumar, Brahma V; Mo, Alisa et al. (2012) Age, CAG repeat length, and clinical progression in Huntington's disease. Mov Disord 27:272-6
Ratovitski, Tamara; Chighladze, Ekaterine; Arbez, Nicolas et al. (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11:2006-21

Showing the most recent 10 out of 55 publications